Nanoform Finland OYJ Logo

Nanoform Finland OYJ

Offers nanoparticle engineering services to enhance drug performance for pharma clients.

NANOFH | ST

Overview

Corporate Details

ISIN(s):
FI4000330972
LEI:
743700JJO2NU8LBS1592
Country:
Finland
Address:
Viikinkaari 4, FI-00790 HELSINKI

Description

Nanoform is a nanoparticle medicine enabling company that provides expert services in drug particle engineering to the global pharmaceutical and biotech industries. The company utilizes its proprietary, scalable Controlled Expansion of Supercritical Solutions (CESS®) technology to enhance the performance of both small and large molecule therapeutics. By creating uniform nanoparticles, Nanoform's services aim to improve drug bioavailability and solubility, enable higher drug loading in smaller dosage forms, and facilitate novel delivery routes such as subcutaneous, long-acting injectable, and inhaled formulations. The company partners with clients throughout the drug development lifecycle to overcome formulation challenges and reduce clinical trial attrition.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Nanoform Finland OYJ filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Nanoform Finland OYJ

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Nanoform Finland OYJ via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

FutureChem Co., Ltd. Logo
Develops radiopharmaceuticals and synthesis equipment for diagnostics and therapy.
South Korea
220100
Future Medicine  Co., Ltd. Logo
Develops nucleoside-based synthetic drugs for antiviral and anticancer applications.
South Korea
341170
Develops sustained-release drugs using a long-acting injectable delivery platform.
South Korea
456160
Gabather AB Logo
Develops therapeutics for CNS disorders by targeting the GABAA receptor system.
Sweden
GABA
Gain Therapeutics, Inc. Logo
Develops allosteric small molecule therapies using an AI drug discovery platform.
United States of America
GANX
Galapagos NV Logo
A biotechnology company focused on a rapid, decentralized cell therapy platform.
Belgium
GLPG
Galderma Group AG Logo
A pharmaceutical company specializing in dermatology and skin health solutions.
Switzerland
GALD
GALECTIN THERAPEUTICS INC Logo
Clinical-stage biopharma developing therapies for fibrotic diseases, liver disease, & cancer.
United States of America
GALT
Galecto, Inc. Logo
Clinical-stage biotech developing small molecule therapeutics for cancer and liver disease.
United States of America
GLTO
Galmed Pharmaceuticals Ltd. Logo
Develops therapeutics for liver, metabolic, and inflammatory diseases.
United States of America
GLMD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.